Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Stephen J. Schuster, MD

Stephen J. Schuster, MD Physician

Director, Lymphoma Program Director, Lymphoma Translational Research Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research

Dr. Schuster is employed by Penn Medicine.

About Dr. Stephen J. Schuster

Recognized by America's Top Doctors 2011 - 2018

Recognized by Best Doctors in America 2005 - 2006, 2011 - 2012, 2015 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues, 2002, and 2010 - 2018

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1989

Clinical Expertise:

  • Lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital
Fellowship: Pennsylvania Hospital


American Association for Cancer Research, National American Society of Clinical Oncology, National American Society of Hematology, National Eastern Cooperative Oncology Group (ECOG), National Leukemia & Lymphoma Society, National

Hospital Affiliation

Dr. Schuster is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.


Selected Publications:

Gopal, Ajay K. Schuster, Stephen J. Fowler, Nathan H. Trotman, Judith. Hess, Georg. Hou, Jing-Zhou. Yacoub, Abdulraheem. Lill, Michael. Martin, Peter. Vitolo, Umberto. Spencer, Andrew. Radford, John. Jurczak, Wojciech. Morton, James. Caballero, Dolores. Deshpande, Sanjay. Gartenberg, Gary J. Wang, Shean-Sheng. Damle, Rajendra N. Schaffer, Michael. Balasubramanian, Sriram. Vermeulen, Jessica. Cheson, Bruce D. Salles, Gilles.: Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study. Journal of Clinical Oncology 36 (23): 2018.

Tsai, Donald E. Bagley, Stephen. Reshef, Ran. Shaked, Abraham. Bloom, Roy D. Ahya, Vivek. Goldberg, Lee. Chung, Albert. Debonera, Fotini. Schuster, Stephen J. Huntington, Scott F.: The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013. American Journal of Hematology 93 (7): 874-881,2018.

Cherng, Hua-Jay J. Sargent, Rachel Lynn. Nasta, Sunita Dwivedy. Svoboda, Jakub. Schuster, Stephen J. Mato, Anthony R. Schrank-Hacker, April. Morrissette, Jennifer J.D. Landsburg, Daniel J.: Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma Leukemia : 2018.

Mato, Anthony R. Thompson, Meghan. Allan, John N. Brander, Danielle M. Pagel, John M. Ujjani, Chaitra S. Hill, Brian T. Lamanna, Nicole. Lansigan, Frederick. Jacobs, Ryan. Shadman, Mazyar. Skarbnik, Alan P. Pu, Jeffrey J. Barr, Paul M. Sehgal, Alison R. Cheson, Bruce D. Zent, Clive S. Tuncer, Hande H. Schuster, Stephen J. Pickens, Peter V. Shah, Nirav N. Goy, Andre. Winter, Allison M. Garcia, Christine. Kennard, Kaitlin. Isaac, Krista. Dorsey, Colleen. Gashonia, Lisa M. Singavi: Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States. Haematologica : 2018.

Thurner, Lorenz. Hartmann, Sylvia. Fadle, Natalie. Kemele, Maria. Bock, Theresa. Bewarder, Moritz. Regitz, Evi. Neumann, Frank. Nimmesgern, Anna. von Müller, Lutz. Pott, Christiane. Kim, Yoo-Jin. Bohle, Rainer Maria. Wasik, Mariusz. Schuster, Stephen J. Hansmann, Martin-Leo. Preuss, Klaus-Dieter. Pfreundschuh, Michael.: LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia : 2018.

Svoboda, Jakub. Rheingold, Susan R. Gill, Saar I. Grupp, Stephan A. Lacey, Simon F. Kulikovskaya, Irina. uhoski, Megan M. Melenhorst, J Joseph. Loudon, Brandon. Mato, Anthony R. Nasta, Sunita Dwivedy. Landsburg, Daniel J. Youngman, Matthew R. Levine, Bruce L. Porter, David L. June, Carl H. Schuster, Stephen J.: Non-viral RNA chimeric antigen receptor modified T cells in patients with Hodgkin lymphoma. Blood : 2018.

Mato, Anthony R. Nabhan, Chadi. Thompson, Chadi. Lamanna, Nicole. Brander, Danielle M. Hill, Brian. Howlett, Christina. Skarbnik, Alan. Cheson, Bruce D. Zent, Clive. Pu, Jeffrey. Kiselev, Pavel. Goy, Andre. Claxton, David. Isaack, Krista. Kennard, Kaitlin H. Timlin, Colleen. Landsburg, Daniel. Winter, Allison. Nasta, Sunita D. Bachow, Spencer H. Schuster, Stephen J. Dorsey, Colleen. Svoboda, Jakub. Barr, Paul. Ujjani, Chaitra S.: Toxicities and outcomes of 616 ibrutinib-treated chronic lymphocytic leukemia patients in the United States: a real-world analysis. Haematologica. 103 (5): 874-879,2018.

Mato, Anthony R. Timlin, Colleen. Ujjani, Chaitra. Skarbnik, Alan. Howlett, Christina. Banerjee, Rahul. Nabhan, Chadi. Schuster, Stephen J.: Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study. British Journal of Haematology. 181 (2): 259-261,2018.

Kremer, Brandon. Tsai, Donald E. Debonera, Fotini. Cohen, Patti L. Schuster, Stephen J.: Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide. Leukemia & Lymphoma. 59 (3): 743-745,2018.

Wang, Jie. Morrissette, Jennifer. Lieberman, David B. Timlin, Colleen. Schuster, Stephen J. Mato, Anthony R.: Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia. British Journal of Haematology. 180 (2): 299-301,2018.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-178
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1846
Patient appointments: 800-789-7366 (PENN)

Related Links